← Leaderboards
Kenneth Lyons Jones
University Of California San Diego
$3,827,842
Attributed
$3,827,842
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $294.9K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,827,842 · 4
By mechanism
U24$3,827,842 · 1
M01$0 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Gerard David Schellenberg$94,178,901
- Robert H Tukey$19,362,771
- Dennis A Carson$36,140,483
- Elizabeth A. Komives$22,830,718
- Igor Grant$65,384,704
Others in their field
Top investigators on “Training”
- Jeffrey P Krischer · University Of South Florida$314,856,919
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Daniel R Kuritzkes · Brigham And Women'S Hospital$258,658,543
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$239,830,683
- Steven E Reis · University Of Pittsburgh At Pittsburgh$232,330,444
Research focus
TrainingFetal Alcohol SyndromeDiagnosisPediatricianDysmorphologyFetal Alcohol ExposureSiteChildParticipantEvaluationInfantPrevalenceClinical ResearchClassificationPhysical ExaminationUkraineFetal Alcohol Spectrum DisorderProtocols DocumentationCharacteristicsNeurobehavioralProgramsAlcoholsIncidenceMalformation
Grant awards (46)
Dysmorphology Research Resource$262,217
U24 · FY2021 · AA · contact PI
Dysmorphology Research Resource$265,455
U24 · FY2020 · AA · contact PI
Dysmorphology Research Resource$225,970
U24 · FY2019 · AA · contact PI
Dysmorphology Research Resource$68,969
U24 · FY2019 · AA · contact PI
Dysmorphology Research Resource$201,221
U24 · FY2018 · AA · contact PI
Dysmorphology Research Resource$201,222
U24 · FY2017 · AA · contact PI
Dysmorphology Core$235,826
U24 · FY2016 · AA · contact PI
Dysmorphology Core$228,750
U24 · FY2015 · AA · contact PI
Dysmorphology Core$242,719
U24 · FY2014 · AA · contact PI
Dysmorphology Core$232,709
U24 · FY2013 · AA · contact PI
Dysmorphology Core$234,410
U24 · FY2012 · AA · contact PI
Dysmorphology Core - U24$155,637
U24 · FY2011 · AA · contact PI
Dysmorphology Core - U24$163,708
U24 · FY2010 · AA · contact PI
Dysmorphology Core - U24$7,000
U24 · FY2010 · AA · contact PI
Dysmorphology Core - U24$162,359
U24 · FY2009 · AA · contact PI
Dysmorphology Core - U24$159,503
U24 · FY2008 · AA · contact PI
Dysmorphology Core - U24$153,891
U24 · FY2007 · AA · contact PI
Dysmorphology Core (U24 Core)$158,693
U24 · FY2005 · AA
Dysmorphology Core (U24 Core)$186,883
U24 · FY2004 · AA
Dysmorphology Core (U24 Core)$280,700
U24 · FY2003 · AA
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2002 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2002 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2002 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2002 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2002 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2002 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2002 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2002 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2001 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2001 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2001 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2001 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2001 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2001 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2000 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2000 · RR
METFORMIN IN TREATMENT OF ADOLESCENTS WITH NIDDM$0
M01 · FY2000 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2000 · RR
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN CHILDREN$0
M01 · FY2000 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2000 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2000 · RR
METFORMIN + INSULIN VS INSULIN MONOTHERAPY IN ADOLESCENT$0
M01 · FY2000 · RR